Hanqi Zhang
Research Subjects
Hanqi Zhang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Duo Yu
The Second Hospital of Jilin University
1 shared publication - Junxuan Yi
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, China
1 shared publication - Mingwei Wang
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, China
1 shared publication - Shunzi Jin
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China
1 shared publication - Wei Kong
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun 130012, China
1 shared publication - Xinfeng Wei
NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun 130012, China
1 shared publication
Latest Publications
- Open Access
Reprogramming Fibrosis: How Protein PTMs Reshape the IPF Proteome
Idiopathic pulmonary fibrosis (IPF) is a fatal and progressive lung disorder. Its pathological process involves persistent epithelial damage, ongoing inflammation, and dysregulated tissue repair. Currently, there are no effective treatment methods to improve patient survival. However, post-translational modifications (PTMs) have gradually garnered widespread attention. They are the processes by which various chemical groups are added to or removed from proteins’ amino acid side chains or the N- or C-terminal ends of the polypeptide chain following synthesis. Additionally, they can regulate the energy supply of cells, regulate the cell cycle, and affect important signaling pathways such as TGF-β. This review systematically summarizes different categories of PTMs, organizes the PTMs involved in various injury stages of IPF, outlines the roles of different cells throughout the process, and analyzes future clinical diagnosis and treatment strategies as well as intervention targets for IPF, providing guiding significance for the systematic intervention of IPF in the future.
Open AccessReprogramming Fibrosis: How Protein PTMs Reshape the IPF Proteome
Idiopathic pulmonary fibrosis (IPF) is a fatal and progressive lung disorder. Its pathological process involves persistent epithelial damage, ongoing inflammation, and dysregulated tissue repair. Currently, there are no effective treatment methods to improve patient survival. However, post-translational modifications (PTMs) have gradually garnered widespread attention. They are the processes by which various chemical groups are added to or removed from proteins’ amino acid side chains or the N- or C-terminal ends of the polypeptide chain following synthesis. Additionally, they can regulate the energy supply of cells, regulate the cell cycle, and affect important signaling pathways such as TGF-β. This review systematically summarizes different categories of PTMs, organizes the PTMs involved in various injury stages of IPF, outlines the roles of different cells throughout the process, and analyzes future clinical diagnosis and treatment strategies as well as intervention targets for IPF, providing guiding significance for the systematic intervention of IPF in the future.